tms
Showing 1 - 4 of 4
Prospective Clinical Cohort Study of Depression
Not yet recruiting
- Major Depressive Disorder
- selective serotonin reuptake inhibitors
- TMS
- (no location specified)
Mar 7, 2023
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +6 more
-
Bethesda, Maryland
- +1 more
Aug 20, 2022
MDD Trial in Prahran (TMS, Sham TMS)
Completed
- Major Depressive Disorder
- TMS
- Sham TMS
-
Prahran, Victoria, AustraliaAlfred Psychiatry Research Centre
Oct 14, 2020
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Disease Trial run by the NCI (Rituximab, Cyclosporine, Allogenic
Completed
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 11, 2019